Transtorno bipolar y dificultades em la adherences al tratamiento
PDF (portugués (Brasil))

Palabras clave

Transtorno bipolar
Adherencia al tratamiento
Psiquiatría

Cómo citar

Transtorno bipolar y dificultades em la adherences al tratamiento. (2026). Revista Eletrônica Acervo Saúde, 26(11), e25339. https://doi.org/10.25248/reas.e25339.2026

Copyright © | Todos los derechos reservados.

La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.

Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.

Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.

Resumen

Objetivo: Por lo tanto, este estudio tiene como objetivo comprender las dificultades en la adherencia al tratamiento del Trastorno Bipolar a través de la literatura, con el fin de apoyar futuros estudios sobre el tema. Métodos: Revisión integradora en la base de datos PubMed utilizando los descriptores: trastorno bipolar Y adherencia, seguida de filtros y criterios previamente determinados. Con el propósito de estructurar la discusión de los artículos, para el análisis se definieron dos categorías: No adherencia al tratamiento y Consecuencias de la adherencia subóptima. Resultados: Se seleccionaron 24 artículos, los cuales 17 corresponden a la primera categoria y 7 a la segunda, los cuales destacan las dificultades y las consecuencias de la falta de adherencia al tratamiento, lo que implica un mayor riesgo de recurrencia, recaídas, hospitalización y empeoramiento del pronóstico. Los desenlaces metabólicos y las comorbilidades psiquiátricas constituyen factores importantes en la ineficacia del tratamiento, pudiendo ocasionar morbilidad precoz. Consideraciones finales: La falta de adherencia al tratamiento de la TB aumenta el riesgo de recaídas, agravamiento de los síntomas y perjuicios en la calidad de vida, además de generar una carga financiera para el sistema de salud. Por lo tanto, el fortalecimiento de la identificación temprana y de las estrategias para mejorar la adherencia se vuelve esencial para los profesionales de la salud.

PDF (portugués (Brasil))

Referencias

AWASTHI S, et al. The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US claims data. Journal of Managed Care & Specialty Pharmacy, 2026; 32(1): 66-74.

BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas: Transtorno Afetivo Bipolar do tipo I. Brasília: Ministério da Saúde, 2016.

BRASIL. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Assistência Farmacêutica e Insumos Estratégicos Relação Nacional de Medicamentos Essenciais: Rename 2024, Brasília: Ministério da Saúde, 2024.

CARVALHO DR, et al. Abordagem integrada no tratamento do transtorno bipolar. Brazilian Journal of Implantology and Health Sciences, 2025; 7(1): 2048-2058.

DE LAS CUEVAS C, et al. Poor adherence to oral psychiatric medication in adults with bipolar disorder: The psychiatrist may have more influence than in other severe mental illnesses. Neuropsychopharmacologia Hungarica, 2021; 23(4): 347-362.

DIABY V, et al. Budget impact of aripiprazole once every 2 months long-acting injectable for adult patients with bipolar I disorder in the United States. Journal of Managed Care & Specialty Pharmacy, 2025; 31(1): 60-68.

DOME P, et al. Risco de suicídio no transtorno bipolar: uma breve revisão. Medicina (Kaunas), 2019; 55(8):403.

FAUGÈRE M, et al. Clinical profiles, treatment adherence, and quality of life in patients with severe mental disorders treated with cyamemazine: A real-world observational study. L’Encéphale, 2025; 51(6): 635-642.

FISCHER R, et al. Treatment Preferences in Acute Psychosis: A Comparison of Patient and Staff Perspectives on Symptom Prioritization and Biopsychosocial Interventions. Psychiatric Quarterly, 2025; 96(1): 1-16.

GLITLIN MJ, MIKLOWITZ DJ. The difficult lives of individuals with bipolar disorder: A review of functional outcomes and their implications for treatment. Journal of Affective Disorders, 2017; 209: 147-154.

JAIN A, MITRA P. Bipolar Disorder. StatPearls, 2023.

KHALIF TC, et al. Terapia de aceitação e compromisso para o transtorno do humor bipolar: um estudo de revisão. Revista Perspectivas, 2025; 16 (2): 458-469.

KHANDKER R, et al. Prevalence and impact of antipsychotic discontinuation among commerc ially insured patients with bipolar disorder. Journal of Medical Economics, 2023; 26(1): 878-885.

LEVIN JB, et al. A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder. Bipolar Disorders, 2024; 26(7): 696-707.

LINTUNEN J, et al. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder – A nationwide cohort study. Journal of Affective Disorders, 2023; 333:403-408

MARZANI G, PRICE NEFF A. Bipolar disorders: Evaluation and treatment. American Family Physician, 2021; 103(4): 227-239.

MCVOY M, et al. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report. Contemporary Clinical Trials, 2022; 115: 106729.

MERIKANGAS KR, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry, 2011; 68(3): 241-251.

MIKLOWITZ DJ, et al. Adjunctive psychotherapy for Bipolar Disorder: A systematic review and component network meta-analysis.JAMA Psychiatry,2021; 78(2): 141–150.

NA JJ, et al. Reducing public stigma toward bipolar disorder: Interventions and outcomes. Journal of Affective Disorders, 2026; 392: 120083.

NIERENBERG AA, et al. Diagnosis and Treatment of Bipolar Disorder: A Review. JAMA, 2023; 330(14):1370-1380.

NIOT C, et al. Clinical pharmacy activities specific to patients treated with lithium. L’Encéphale, 2025; 51(6): 592-600.

OLIVEIRA AT, et al. Estratégias farmacológicas no Transtorno Bipolar de difícil tratamento. Journal of Medical and Biosciences Research, 2025; 2(5): 997 – 1005.

PEREIRA CS, et al. A grounded theory on acceptance of diagnosis as a pathway to recovery in bipolar disorder. Scientific Reports, 2024; 14(1): 13434.

PERKINS AJ, et al. Association of antipsychotic-related weight gain with treatment adherence and switching using electronic medical records data. Prim Care Companion CNS Disord, 2023; 25(2): 22m03310.

POOJARI PG, et al. Consumers’ and practitioners’ perspectives on the antipsychotic induced metabolic syndrome and challenges in metabolic monitoring to patient prescribed second generation antipsychotics in severe mental illness. Journal of Health Psychology, 2025; 30(14): 4513-4527.

PRAJAPATI AR, et al. A qualitative investigation of the modifiable determinants of medication adherence in bipolar disorder (BD): Views of patients and their family and friends. Journal of Affective Disorders, 2025; 382: 462-470.

RAHIMI CHAHOOEI M, et al. Executive function performance in high and low medication adherent patients with euthymic bipolar I disorder: A comparative study. BMC Psychiatry, 2025; 25(1): 239.

SAJATOVIC M, et al. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients with Bipolar Disorder. Prim Care Companion CNS Disord, 2021; 23(5): 20m02888.

SAJATOVIC M, et al. Association Between Adherence Barriers, Self-Reported Adherence, and Psychiatric Symptoms Among Adults with Bipolar Disorder. Bipolar Disorders, 2025; 27(8): 567-577.

SAJATOVIC M, et al. Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges. Psychopharmacology Bulletin, 2024; 54(3): 60-72.

SENNER F, et al. Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study. Translational Psychiatry, 2023; 13(1): 99.

TAMBUZZI S, et al. Mood disorders and suicide: pilot study on postmortem toxicologic evidence and adherence to psychiatric therapy by determining blood levels of medications. International Journal of Legal Medicine, 2025; 139(1): 319-334.

TAMENE FB, et al. Medication non-adherence and its predictors among patients with bipolar disorder in Northwest Ethiopia. Scientific Reports, 2025; 15(1): 1192.

TAVEIRA CO, et al. Psicoeducação no transtorno bipolar: uma revisão sistemática Archives of Health, 2024; 5 (3): 01-08.

VU TS, et al. Factors associated with treatment non-adherence among patients with bipolar disorder in Vietnam. East Asian Archives of Psychiatry, 2025; 35(1): 32-36.

ZAFRA VB, et al. Transtorno bipolar e o dilema na adesão ao tratamento medicamentoso: Revisão de literatura. COORTE - Revista Científica Do Hospital Santa Rosa, 2024; 17(17).

ZHONG Y, et al. Global, regional and national burdens of bipolar disorders in adolescents and young adults: A trend analysis from 1990 to 2019. General Psychiatry, 2024; 37(1): e101255.